Latest Coral Laboratories stock price
Coral Laboratories P/E Ratio
CORALAB • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
6.35
Low Valuation
Very Low - Potentially undervalued or facing challenges
Current Valuation Metrics
P/E Ratio
6.35
Current Price
₹429.40
EPS (TTM)
₹67.61
Exchange
BSE
Valuation Signal
Signal
Undervalued
Sector Context
Sector Average
48.09
Sector Median
27.37
Sector Rank
#4 of 140
Sector Percentile
2.9%
Key P/E Ratio Insights for Coral Laboratories
- Stock appears undervalued with PE of 6.35, suggesting potential buying opportunity
- Trading at discount to sector average PE of 48.09
View the CORALAB equity price for detailed stock performance.
Related Pages for Coral Laboratories
Additional stock information and data for CORALAB
Sector P/E Ratio Comparison
Comparing Coral Laboratories with other companies in Healthcare sector
Sector Average
48.09
Sector Median
27.37
Lowest P/E
1.1
Highest P/E
754.17
Companies
140
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.1 | ₹38 | Low |
| Murae Organisor | MURAE | 3.14 | ₹47 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.87 | ₹1,186 | Low |
| Amwill Health Care | AMWILL | 6.5 | ₹67 | Low |
| Medicamen Organics | MEDIORG | 6.94 | ₹27 | Low |
| JFL Life Sciences | JFLLIFE | 7.53 | ₹36 | Low |
| Galaxy Medicare | GML | 7.66 | ₹26 | Low |
| Unichem Laboratories | UNICHEMLAB | 8.42 | ₹2,437 | Low |
| Zenith Drugs | ZENITHDRUG | 9.03 | ₹85 | Low |
| Brooks Laboratories | BROOKS | 9.44 | ₹198 | Low |